Hidden Charcot-Marie-Tooth 1A as Revealed by Peripheral Nerve Imaging

Internal Medicine - Tập 58 Số 21 - Trang 3157-3161 - 2019
Kazumoto Shibuya1, Tomio Yoshida1, Sonoko Misawa1, Yukari Sekiguchi1, Minako Beppu1, Hiroshi Amino1, Yoichi Suzuki1, Tomoki Suichi1, Atsuko Tsuneyama1, Keigo Nakamura1, Satoshi Kuwabara1
1Department of Neurology, Graduate School of Medicine, Chiba University, Japan

Tóm tắt

Từ khóa


Tài liệu tham khảo

1. Shibuya K, Sugiyama A, Ito S, et al. Reconstruction magnetic resonance neurography in chronic inflammatory demyelinating polyneuropathy. Ann Neurol 77: 333-337, 2015.

2. Sugimoto T, Ochi K, Hosomi N, et al. Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot-Marie-Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy. J Neurol 260: 2580-2587, 2013.

3. Zaidman CM, Harms MB, Pestronk A. Ultrasound of inherited vs. acquired demyelinating polyneuropathies. J Neurol 260: 3115-3121, 2013.

4. Grimm A, Rattay TW, Winter N, Axer H. Peripheral nerve ultrasound scoring systems: benchmarking and comparative analysis. J Neurol 264: 243-253, 2017.

5. Ginsberg L, Malik O, Kenton AR, et al. Coexistent hereditary and inflammatory neuropathy. Brain 127: 193-202, 2004.

6. Attarian S, Azulay JP, Boucraut J, Escande N, Pouget J. Terminal latency index and modified F ratio in distinction of chronic demyelinating neuropathies. Clin Neurophysiol 112: 457-463, 2001.

7. Kuwabara S, Ogawara K, Misawa S, Mori M, Hattori T. Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol, Neurosurg, Psychiatry 72: 37-42, 2002.

8. Decard BF, Pham M, Grimm A. Ultrasound and MRI of nerves for monitoring disease activity and treatment effects in chronic dysimmune neuropathies - Current concepts and future directions. Clin Neurophysiol 129: 155-167, 2018.

9. Krajewski KM, Lewis RA, Fuerst DR, et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 123: 1516-1527, 2000.

10. Kuwabara S, Isose S, Mori M, et al. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy. J Neurol, Neurosurg, Psychiatry 86: 1054-1059, 2015.

11. Mathey EK, Park SB, Hughes RA, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol, Neurosurg, Psychiatry 86: 973-985, 2015.

12. Grimm A, Vittore D, Schubert V, et al. Ultrasound pattern sum score, homogeneity score and regional nerve enlargement index for differentiation of demyelinating inflammatory and hereditary neuropathies. Clin Neurophysiol 127: 2618-2624, 2016.

13. Khadilkar SV, Yadav RS, Soni G. A practical approach to enlargement of nerves, plexuses and roots. Pract Neurol 15: 105-115, 2015.

14. Ishigami N, Kondo M, Nakagawa M. [Case of Charcot-Marie-Tooth disease type 1A with increased cerebrospinal fluid proteins and nerve root hypertrophy]. Rinsho Shinkeigaku 48: 419-421, 2008 (in Japanese, Abstract in English).

15. Rajabally YA, Adams D, Latour P, Attarian S. Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses. J Neurol, Neurosurg, Psychiatry 87: 1051-1060, 2016.

16. Pareyson D, Testa D, Morbin M, et al. Does CMT1A homozygosity cause more severe disease with root hypertrophy and higher CSF proteins? Neurology 60: 1721-1722, 2003.